You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 9, 2025

Litigation Details for University of Western Australia v. Academisch Ziekenhuis Leiden (D. Del. 2016)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in University of Western Australia v. Academisch Ziekenhuis Leiden
The small molecule drug covered by the patent cited in this case is ⤷  Try for Free .

Details for University of Western Australia v. Academisch Ziekenhuis Leiden (D. Del. 2016)

Date FiledDocument No.DescriptionSnippetLink To Document
2016-02-25 1 Interference”) between U.S. Patent No. 8,486,907 (“the UWA ’907 patent”) assigned to Plaintiff University…issued as U.S. Patent No. 7,807,816 (“the UWA ’816 patent”), which is one of the UWA patents involved in…rulings of the Patent Trial and Appeal Board (the “PTAB”) of the United States Patent and Trademark Office…the owner of the UWA ’907 patent. The exclusive licensee of the UWA ’907 patent, Sarepta, has the power…907 patent, as well as the power and right to contest interferences involving the UWA ’907 patent. External link to document
>Date Filed>Document No.>Description>Snippet>Link To Document
Showing 1 to 1 of 1 entries

Litigation summary and analysis for: University of Western Australia v. Academisch Ziekenhuis Leiden (D. Del. 2016)

Based on the search results provided, I do not have enough specific information to provide a litigation summary and analysis for the case "University of Western Australia v. Academisch Ziekenhuis Leiden|1:16-cv-00109-LPS-CJ". The search results do not contain details about this particular case.

However, I can provide some general information that may be relevant:

  1. There was a notable case involving the University of Western Australia (UWA) and one of its former employees, Professor Bruce Gray, regarding intellectual property rights. This case was "University of Western Australia v Gray" [1].

  2. The key points from the UWA v Gray case were:

  • It involved a dispute over ownership of intellectual property developed by Professor Gray while employed at UWA.
  • The court ruled that Professor Gray owned the intellectual property rights to inventions he developed while employed by the university.
  • This decision was significant for how universities handle intellectual property rights with their academic staff.
  1. Academisch Ziekenhuis Leiden, also known as Leiden University Medical Center (LUMC), is a major medical center in the Netherlands [2]. However, I don't have specific information about any litigation involving this institution and UWA.

  2. The case number "1:16-cv-00109-LPS-CJ" suggests this may be a U.S. federal court case, but I don't have details about the specific litigation.

Without more specific information about the case "University of Western Australia v. Academisch Ziekenhuis Leiden|1:16-cv-00109-LPS-CJ", I cannot provide a detailed litigation summary or analysis. If you have any additional details or specific questions about aspects of university intellectual property disputes or international academic collaborations, I'd be happy to try to address those based on the general information available.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.